Finer v. Boehringer Ingelheim Pharmaceuticals, Inc., 19-CV-11391 (ALC). (2020)
Court: District Court, S.D. New York
Number: infdco20200121883
Visitors: 7
Filed: Jan. 13, 2020
Latest Update: Jan. 13, 2020
Summary: ORDER ANDREW L. CARTER, JR. , District Judge . The Court is in receipt of the parties' January 8, 2020 joint letter requesting that this action be stayed pending the determination by the Judicial Panel on Multidistrict Litigation ("JPML") of a pending application for a Multidistrict Litigation ("MDL") proceeding, and transfer to the appropriate transferee court of this case and other related cases. That request is GRANTED. Accordingly, this action is STAYED pending the decision of the JPML
Summary: ORDER ANDREW L. CARTER, JR. , District Judge . The Court is in receipt of the parties' January 8, 2020 joint letter requesting that this action be stayed pending the determination by the Judicial Panel on Multidistrict Litigation ("JPML") of a pending application for a Multidistrict Litigation ("MDL") proceeding, and transfer to the appropriate transferee court of this case and other related cases. That request is GRANTED. Accordingly, this action is STAYED pending the decision of the JPML ..
More
ORDER
ANDREW L. CARTER, JR., District Judge.
The Court is in receipt of the parties' January 8, 2020 joint letter requesting that this action be stayed pending the determination by the Judicial Panel on Multidistrict Litigation ("JPML") of a pending application for a Multidistrict Litigation ("MDL") proceeding, and transfer to the appropriate transferee court of this case and other related cases. That request is GRANTED. Accordingly, this action is STAYED pending the decision of the JPML in In re Zantac/Ranitidine NDMA Litig., MDL No. 2924 and all deadlines, including Defendants' obligation to respond to the Complaint, are STAYED until further order of the Court.
SO ORDERED.
Source: Leagle
